Stay updated on AEB1102 in Arginase I Deficiency Clinical Trial
Sign up to get notified when there's something new on the AEB1102 in Arginase I Deficiency Clinical Trial page.
Latest updates to the AEB1102 in Arginase I Deficiency Clinical Trial page
- Check3 days agoChange DetectedRevision metadata updated: added Revision: v3.3.4 and removed Revision: v3.3.3.SummaryDifference0.1%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedLocations section added with the listed sites (California, Florida, Michigan, New York, Texas, Washington, Ontario) and the page revision updated to v3.3.3; the old location headings and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.9%
- Check53 days agoChange DetectedMinor wording changes in the Publications section and a revision label update were made; these edits do not affect study data or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check60 days agoChange DetectedRemoved the government funding status notice from the page, a non-critical operational detail. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check74 days agoChange DetectedNo significant additions or deletions were detected; the page's substantive content such as study details, eligibility criteria, and outcomes remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check103 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference5%
Stay in the know with updates to AEB1102 in Arginase I Deficiency Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AEB1102 in Arginase I Deficiency Clinical Trial page.